Medicare Enrolled

Dr. Galo Rodarte, M.D.

Endocrinology · El Paso, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
400 E ROBINSON AVE, El Paso, TX 79902
9155329220
In practice since 2006 (19 years)
NPI: 1376585489 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodarte from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodarte? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodarte

Dr. Galo Rodarte is an endocrinology in El Paso, TX, with 19 years in practice. Based on federal Medicare data, Dr. Rodarte performed 6,380 Medicare services across 2,022 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rodarte received a total of $6,325 from 33 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodarte is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 7% volume in TX$ $6,325 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,380
Medicare services
Top 7% in TX for endocrinology
2,022
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~336 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,740$17$37
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)543$38$83
Office visit, established patient (30-39 min)405$83$207
Betamethasone steroid injection389$4$40
Drug injection, under skin or into muscle302$9$48
Chronic care management, first 20 min/month288$42$82
Urine microalbumin (protein) analysis278$6$15
Creatinine test (kidney function)278$5$15
Urinalysis, manual274$3$16
Ceftriaxone antibiotic injection258$0$30
Electrocardiogram (EKG), 12-lead210$9$70
Test to measure expiratory airflow and volume184$18$68
Face-to-face behavioral counseling for obesity, 15 minutes150$24$50
Annual depression screening102$17$35
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes102$25$50
Office visit, established patient, complex (40-54 min)101$113$281
Psychotherapy with evaluation and management visit, 30 minutes72$49$131
Detection test by immunoassay with direct visual observation for influenza virus62$15$40
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)62$15$35
Annual alcohol misuse screening, 5 to 15 minutes60$17$35
Test to measure expiratory airflow and volume changes before and after medication administration58$27$116
Inhalation treatment for airway obstruction or sputum production57$6$35
Annual wellness visit, follow-up53$124$225
Testing for presence of drug, read by direct observation46$12$35
Test to measure exhaled air for evaluation of lung function at rest43$28$93
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a41$30$79
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow33$79$209
Influenza vaccine, quadrivalent derived from cell cultures32$31$65
Flu vaccine administration29$30$48
Ultrasound of leg arteries or artery grafts28$136$413
Ultrasound study of arm or leg veins with compression and maneuvers27$68$304
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use21$283$530
Pneumonia vaccine administration21$30$48
Ultrasound of leg arteries at rest and after exercise17$78$280
Echocardiogram, transthoracic14$76$400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
43.3% medium
56.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,325
Total received (2018-2024)
Avg $904/year across 7 years
Top 40% in TX for endocrinology
33
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,016 (95.1%)
Other
Charitable contributions, space rental, and other categories
$172 (2.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$238
2023
$590
2022
$819
2021
$689
2020
$386
2019
$1,405
2018
$2,199

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$806
Lilly USA, LLC
$518
Merck Sharp & Dohme Corporation
$505
GlaxoSmithKline, LLC.
$410
Takeda Pharmaceuticals U.S.A., Inc.
$373
Novo Nordisk Inc
$337
SANOFI-AVENTIS U.S. LLC
$319
Amarin Pharma Inc.
$308
ABBVIE INC.
$285
AbbVie Inc.
$239
Insulet Corporation
$202
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Kowa Pharmaceuticals America, Inc.
$171
AbbVie, Inc.
$154
Amgen Inc.
$145
Abbott Laboratories
$142
PFIZER INC.
$139
Astellas Pharma US Inc
$137
Corcept Therapeutics
$131
Janssen Pharmaceuticals, Inc
$125
Baxter Healthcare
$115
MannKind Corporation
$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
ARBOR PHARMACEUTICALS, INC.
$82
Dexcom, Inc.
$76
Welch Allyn
$57
Novartis Pharmaceuticals Corporation
$46
Radius Health, Inc.
$32
Gilead Sciences, Inc.
$27
Sanofi Pasteur Inc.
$17
Mylan Specialty L.P.
$16
Merck Sharp & Dohme LLC
$14
Arbor Pharmaceuticals, Inc.
$14
Top 3 companies account for 28.9% of total payments
Associated products mentioned in payments ›
AFREZZA · ANORO · AREXVY · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · COSENTYX · Dexcom G6 Transmitter · Dexilant · Dymista · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL 9 · INVOKANA · JANUMET · JANUVIA · JARDIANCE · Korlym · LEQVIO · LIVALO · Livalo · MOUNJARO · MYRBETRIQ · None · OFEV · Omnipod · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · Uloric · Vascepa · XARELTO · XIFAXAN · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $99 per 100 Medicare services performed
Looking for a endocrinology in El Paso?
Compare endocrinologys in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
13
Per 100K population
1.5
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rodarte is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rodarte experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rodarte performed 1,740 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodarte receive payments from pharmaceutical companies?
Yes. Dr. Rodarte received a total of $6,325 from 33 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodarte's costs compare to other endocrinologys in El Paso?
Dr. Rodarte's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodarte) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →